Latest news with #ThomasFancutt
7NEWS
a day ago
- Sport
- 7NEWS
Australian tennis player Thomas Fancutt hit with 10-month doping ban
Australian doubles player Thomas Fancutt has issued a statement after accepting a 10-month doping ban from the International Tennis Integrity Agency (ITIA). The ITIA sent Fancutt 'a notice of a potential anti-doping rule violation' on March 7 this year, and he immediately requested to enter a voluntary provisional suspension as the investigation took place. Now, after all the evidence has been gathered, Fancutt has admitted to the breach and been suspended. The suspension follows an 18-month doping ban to Aussie tennis star Max Purcell (who was ranked as high as No.8 in doubles) just a handful of months ago. Fancutt said he 'unknowingly violated an anti-doping rule' when taking an intravenous vitamin infusion. Purcell's ban also followed an IV infusion of vitamins. 'The ITIA sent the player (Fancutt) a notice of a potential anti-doping rule violation (ADRV) on 7 March 2025,' the ITIA said. 'Following a full investigation by the ITIA ... Fancutt admitted to the breach, and the ITIA accepted that the breach was not intentional. 'The ITIA considered relevant precedents across all WADC-compliant sports, in addition to the player's early admission and full co-operation.' Fancutt accepted his intravenous infusion in December 2024 was over the accepted limit — the limit under the World Anti-Doping Code (WADC) and TADP is 100ml in a 12-hour period. Fancutt — who reached a career-high world doubles ranking of 107 in December 2024 — is expected return in January next year (the ban ends on January 18) and could play in the Australian Open. In the meantime, he will however forfeit results and prize money from the date of his first anti-doping rule violation on December 3, 2024, to the first subsequent negative doping control sample, which was provided on January 16, 2025. Fancutt said he was devastated but stressed it was an accident. 'To the International tennis community, at the end of my 2024 season, I unknowingly violated an anti-doping rule by receiving a 500ml IV infusion to combat severe fatigue,' he said on social media. 'The contents of the infusion were solely Vitamin B, Vitamin C and magnesium. The IV infusion amount however exceeded 100mls which regardless of its content is prohibited under anti-doping regulations, something I was completely unaware of at the time. 'I have always taken great pride in being a clean athlete, and this situation has been devastating for me. While I am deeply disappointed by the suspension, I remain fully committed to the sport and look forward to returning to competition as soon as this matter is resolved. 'During the time, I am fully cooperating with the ITIA and am incredibly grateful for the support of the PTPA and everyone standing by me. I appreciate your understanding and support, and I can't wait to be back on tour.'
Hindustan Times
a day ago
- Sport
- Hindustan Times
Australia tennis player receives 10-month doping suspension, ITIA accepts explanation
Aussie tennis ace Thomas Fancutt has accepted a ten-month suspension for a doping violation. The suspension was given by the International Tennis Integrity Agency (ITIA), and the 30-year-old was also placed under voluntary provisional suspension in March. During the investigation, the player accepted the doping breach, and the ITIA also accepted his explanation.(HT_PRINT) During the investigation, the player accepted the doping breach, and the ITIA also accepted his explanation that it was accidental. His suspension will last till January 18, 2026, as the time in his provisional suspension will also be counted. The ITIA in its statement said, '30-year-old Fancutt, who reached a career-high world doubles ranking of 107 in December 2024, admitted to breaching Article 2.2 of the TADP (use of a Prohibited Method) by receiving an intravenous infusion over the accepted limit on 3 December 2024. The limit under the World Anti-Doping Code (WADC) and TADP is 100mL in a 12-hour period.' The statement further added, 'Time served under the voluntary provisional suspension is credited against the period of ineligibility. As such, Fancutt's suspension will end on 18 January 2026. The player will also forfeit results and prize money from the date of their first ADRV (3 December 2024) to their first subsequent negative doping control sample, which was provided on 16 January 2025. During the period of ineligibility, Fancutt is prohibited from playing in, coaching at, or attending any tennis event authorised or sanctioned by the members of the ITIA (ATP, ITF, WTA, Tennis Australia, Fédération Française de Tennis, Wimbledon and USTA) or any national association.' Fancutt has a career-high singles ranking of 382, and currently, he is 723rd in the ATP leaderboard. In doubles, he has a career-high ranking of 107.
Daily Mail
2 days ago
- Sport
- Daily Mail
Aussie tennis player slapped with hefty ban after admitting to doping breach
Thomas Fancutt has become the second Australian player to receive a ban this year after admitting to a breach of the sport's rules against anti-doping. Fellow Aussie Max Purcell, who reached a career high ATP Tour singles ranking of 40 back in 2023, accepted an 18-month suspension after he breached the International Tennis Integrity Agency's (ITIA) doping rules. On Thursday, the ITIA confirmed that Fancutt had accepted a 10-month suspension. He had admitted to a breach of Article 2.2 of the Tennis Anti-Doping Programme (TADP) relating to the use of a 'prohibited method'. Purcell had admitted to contravening the same provision back in December before being handed his suspension in April. He received two infusions that were over 500ml back in 2023. His cooperation had resulted in a reduction in his sanction. However, he missed the Australian Open in January after entering a voluntary provisional suspension. Fancutt, meanwhile, had contravened the regulation after he received an intravenous infusion that was deemed to be over the limit permitted by the TADP in December 2025. Under the governing body's rules, players are only allowed to receive a 100ml infusion across a 12-hour period. Fancutt's suspension will expire before the 2026 Australian Open. Following an investigation, the ITIA explained that Fancutt had admitted to the breach, and had informed the governing body that it was not intentional. 'The ITIA sent the player a notice of a potential Anti-Doping Rule Violation (ADRV) on 7 March 2025. On 19 March 2025, the player requested to enter into a voluntary provisional suspension, which came into effect immediately,' the ITIA's statement read. 'Following a full investigation by the ITIA, which included evidence gathering and interviews with the player, Fancutt admitted to the breach, and the ITIA accepted that the breach was not intentional. 'In determining sanction, the ITIA considered relevant precedents across all WADC-compliant sports, in addition to the player's early admission and full co-operation.' His time served under the voluntary provisional suspension will be credited back to his ban. During his suspension, the ITIA states that he is banned from playing in, coaching or attending any tennis event authorised by the ATP Tour, WTA Tour or Tennis Australia. In March, the 30-year-old Aussie, who reached a career-high singles ranking of 107, spoke of his 'devastation' following the news. 'At the end of my 2024 season, I unknowingly violated an anti-doping rule by receiving a 500ml IV infusion to combat severe fatigue,' he wrote in an Instagram story earlier this year. 'The contents of the infusion were solely vitamin B, vitamin C and magnesium. 'The IV infusion amount, however, exceeded 100mls which regardless of its contents, is prohibited under anti-doping regulations, something I was completely unaware of at the time.'
Sydney Morning Herald
2 days ago
- Sport
- Sydney Morning Herald
Australian tennis player hit with 10-month ban for anti-doping breach over vitamin infusion
A second Australian tennis player in four months has been hit with a lengthy suspension for breaching the sport's anti-doping rules over intravenous infusion of vitamins. Thomas Fancutt, 30, was provisionally suspended in April but the sport's anti-doping watchdog, the International Tennis Integrity Agency (ITIA), hit the doubles player with a 10-month ban on Tuesday – a suspension which ends in January before the Australian Open. Fancutt has admitted to using a 'prohibited method' as defined by the ITIA's anti-doping program. Athletes are permitted to use IV drips, but only when fluid is below a certain threshold and within a specific time period. Fancutt's case follows that of Australia's doubles champion Max Purcell who was hit with an 18-month ban in April for breaching the anti-doping rules after ITIA investigators found messages on his mobile phone in which he discussed ways he could justify receiving intravenous infusions. Two-time grand slam doubles champion Purcell was also found by the ITIA to have used a 'prohibited method' – by receiving infusions of more than 500 millilitres in December 2023. In Fancutt's case, the ITIA said the player had received an intravenous infusion over the accepted limit in December, 2024. 'The ITIA sent the player a notice of a potential anti-doping rule violation (ADRV) on 7 March 2025,' the agency said in a statement. 'On 19 March 2025, the player requested to enter into a voluntary provisional suspension, which came into effect immediately. 'Following a full investigation by the ITIA, which included evidence gathering and interviews with the player, Fancutt admitted to the breach, and the ITIA accepted that the breach was not intentional.
The Age
2 days ago
- Sport
- The Age
Australian tennis player hit with 10-month ban for anti-doping breach over vitamin infusion
A second Australian tennis player in four months has been hit with a lengthy suspension for breaching the sport's anti-doping rules over intravenous infusion of vitamins. Thomas Fancutt, 30, was provisionally suspended in April but the sport's anti-doping watchdog, the International Tennis Integrity Agency (ITIA), hit the doubles player with a 10-month ban on Tuesday – a suspension which ends in January before the Australian Open. Fancutt has admitted to using a 'prohibited method' as defined by the ITIA's anti-doping program. Athletes are permitted to use IV drips, but only when fluid is below a certain threshold and within a specific time period. Fancutt's case follows that of Australia's doubles champion Max Purcell who was hit with an 18-month ban in April for breaching the anti-doping rules after ITIA investigators found messages on his mobile phone in which he discussed ways he could justify receiving intravenous infusions. Two-time grand slam doubles champion Purcell was also found by the ITIA to have used a 'prohibited method' – by receiving infusions of more than 500 millilitres in December 2023. In Fancutt's case, the ITIA said the player had received an intravenous infusion over the accepted limit in December, 2024. 'The ITIA sent the player a notice of a potential anti-doping rule violation (ADRV) on 7 March 2025,' the agency said in a statement. 'On 19 March 2025, the player requested to enter into a voluntary provisional suspension, which came into effect immediately. 'Following a full investigation by the ITIA, which included evidence gathering and interviews with the player, Fancutt admitted to the breach, and the ITIA accepted that the breach was not intentional.
